Medicines Co (NASDAQ:MDCO)

48.70
Delayed Data
As of Sep 16
 +0.94 / +1.97%
Today’s Change
16.69
Today|||52-Week Range
49.20
+154.44%
Year-to-Date
Company News For Sep 4, 2019
Sep 04 / Zacks.com - Paid Partner Content
Here's Why The Medicines Company Stock Soared Again on Tuesday
Sep 03 / MotleyFool.com - Paid Partner Content
What Happened in the Stock Market Today
Sep 03 / MotleyFool.com - Paid Partner Content
Why Tilray, Conn's, and Medicines Company Jumped Today
Sep 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.76
Today’s open47.74
Day’s range47.69 - 49.20
Volume1,728,963
Average volume (3 months)1,849,642
Market cap$3.8B
Data as of 4:00pm ET, 09/16/2019

Growth & Valuation

Earnings growth (last year)+59.44%
Earnings growth (this year)-86.39%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)-86.30%
P/E ratioNM
Price/Sales229.42
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.53+2.38%
MRTXMirati Therapeutics ...+0.98+1.15%
RAREUltragenyx Pharmaceu...+0.66+1.50%
UTHRUnited Therapeutics ...+2.84+3.52%
Data as of 4:00pm ET, 09/16/2019

Financials

Next reporting dateOctober 23, 2019
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$6.1M
Annual profit (last year)-$292.1M
Net profit margin-3,832.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Innovation Officer &
Director
Clive A. Meanwell
Chief Executive Officer &
Director
Mark Timney
Corporate headquarters
Parsippany, New Jersey

Forecasts